You are here

Article info

Article menu
Download PDFPDF
EBM Verdict
General medicine
Lorcaserin in obesity: minimal benefits and ill-defined harms

Authors

  1. Correspondence to Dr Igho J Onakpoya, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; igho.onakpoya{at}phc.ox.ac.uk
View Full Text

Citation

Onakpoya IJ, Aronson JK
Lorcaserin in obesity: minimal benefits and ill-defined harms
BMJ Evidence-Based Medicine 2019;24:145-146.

Publication history

  • Accepted November 16, 2018
  • First published January 30, 2019.
Online issue publication 
July 31, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.